Skip to main content

GENELUX Corp

GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001231457

In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding GENELUX Corp changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of GNLX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders6157−4
Shares7.39M7.45M+55.7K (+0.8%)
Value$21.1M$31.3M+$10.1M (+48.0%)

New holders (6)

Institutions that held GENELUX Corp at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to GNLX in Q3 2025
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP52,383$220.0K0.00%
Citadel Advisors LLC34,243$143.8K0.00%
Integrity Alliance, LLC.15,052$63.2K0.00%
Tower Research Capital LLC (TRC)471$1.98K0.00%
EverSource Wealth Advisors, LLC150$6300.00%
Citigroup Inc1$40.00%

Sold out (10)

Institutions that held GENELUX Corp at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of GNLX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Dauntless Investment Group, LLC123,194$263.3K
Squarepoint Ops LLC58,574$168.1K
Mariner, LLC30,030$86.2K
Two Sigma Investments, LP24,992$71.7K
Cubist Systematic Strategies, LLC22,713$65.2K
Millennium Management LLC22,136$63.5K
Jane Street Group, LLC10,774$30.9K
Mercer Global Advisors Inc10,750$30.9K
Point72 (DIFC) Ltd242$695
Simplex Trading, LLC163$0